Integrated BiopharmaINBP
13F holders, Q1 2024 (March 31)1holders
$0.19avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Integrated Biopharma Inc. (INBP) in their 13F filings. The largest holder was Moloney Securities Asset Management, LLC ($4K).
- Company
- Integrated Biopharma Inc.
- CUSIP
- 45811V105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Moloney Securities Asset Management, LLC | 0.00% | No change | 20,000 | $4K |
"% of holder's portfolio" is INBP's weight in each manager's 13F, not the share of Integrated Biopharma Inc. the manager owns.